A Multi-Center Randomized Study to Evaluate the Efficacy and Safety of an Investigational Lubricant Eye Drop

Allergan

Status and phase: Completed; Phase 3; Phase 2

Conditions: Dry Eye

Treatments: Drug: Carboxymethylcellulose sodium and Glycerin

Study type: Interventional

Funder types: Industry

Identifiers

NCT00243711

AG9689-001

Details and patient eligibility

About

The efficacy, safety and acceptability of an investigational lubricant eye drop in subjects with dry eye will be evaluated in comparison with currently-available lubricant eye drops.

Enrollment: 286 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Mild, Moderate, or Severe Dry Eye Symptoms and current eye drop use;
• Reduced tear stability or tear production

Exclusion criteria

• NONE

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind